These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19609542)

  • 21. [Influencing the prescriptions of general practitioners via guidelines and feedback--secondary publication].
    Schaefer K; Hansen AO; Maerkedahl H; Rehfeld C; Birk HO; Henriksen LO
    Ugeskr Laeger; 2008 Dec; 170(49):4030-2. PubMed ID: 19127691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.
    Ohlsson H; Merlo J
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):682-90. PubMed ID: 19437457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary medicine prescription patterns in Germany.
    Schneider B; Hanisch J; Weiser M
    Ann Pharmacother; 2004 Mar; 38(3):502-7. PubMed ID: 14755068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expert report on psoriasis: Spanish dermatologists' opinions on the use of biologic agents to manage moderate to severe psoriasis in adults.
    Puig L; de la Cueva P; Linares M; Suarez J; Velasco M; Vidal D; Zulaica A; García-Calvo C
    Actas Dermosifiliogr; 2013 Jun; 104(5):400-8. PubMed ID: 23669590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knee osteoarthritis clinical practice guidelines -- how are we doing?
    DeHaan MN; Guzman J; Bayley MT; Bell MJ
    J Rheumatol; 2007 Oct; 34(10):2099-105. PubMed ID: 17722223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity in the treatment of moderately severe scalp psoriasis in Scotland - results of a survey of Scottish health professionals.
    Smith DR; Bottomley JM; Auland M; Jackson P; Sharp J
    Curr Med Res Opin; 2011 Jan; 27(1):239-49. PubMed ID: 21142837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug supply for children with psoriasis in Germany.
    Augustin M; Reich K; Glaeske G; Kämpfe S; Radtke MA; Gerdau-Heitmann C; Schicktanz C; Schäfer I
    J Dtsch Dermatol Ges; 2013 Aug; 11(8):751-5. PubMed ID: 23718227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of vitiligo patients and attitude of dermatologists towards vitiligo.
    Ongenae K; Van Geel N; De Schepper S; Vander Haeghen Y; Naeyaert JM
    Eur J Dermatol; 2004; 14(3):177-81. PubMed ID: 15246945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders.
    Roelofzen JH; Aben KK; Khawar AJ; Van de Kerkhof PC; Kiemeney LA; Van Der Valk PG
    Eur J Dermatol; 2007; 17(5):416-21. PubMed ID: 17673386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.
    Huang W; Cordoro KM; Taylor SL; Feldman SR
    J Am Acad Dermatol; 2008 Jun; 58(6):970-7. PubMed ID: 18384909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing use of more potent treatments for psoriasis.
    Strowd LC; Yentzer BA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2009 Mar; 60(3):478-81. PubMed ID: 19058875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three years after the publication of the German (S3) evidence based psoriasis guidelines--was it worth the effort?
    Nast A; Rzany B
    J Dtsch Dermatol Ges; 2009 Dec; 7(12):1044-7. PubMed ID: 19817948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changed patterns in Dutch palliative sedation practices after the introduction of a national guideline.
    Hasselaar JG; Verhagen SC; Wolff AP; Engels Y; Crul BJ; Vissers KC
    Arch Intern Med; 2009 Mar; 169(5):430-7. PubMed ID: 19273772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [S3-Guidelines for the therapy of psoriasis vulgaris].
    Nast A; Kopp IB; Augustin M; Banditt KB; Boehncke WH; Follmann M; Friedrich M; Huber M; Kahl C; Klaus J; Koza J; Kreiselmaier I; Mohr J; Mrowietz U; Ockenfels HM; Orzechowski HD; Prinz J; Reich K; Rosenbach T; Rosumeck S; Schlaeger M; Schmid-Ott G; Sebastian M; Streit V; Weberschock T; Rzany B;
    J Dtsch Dermatol Ges; 2006 Nov; 4 Suppl 2():S1-126. PubMed ID: 17187649
    [No Abstract]   [Full Text] [Related]  

  • 35. Prescribing patterns of anti-emetic drugs during pregnancy in Germany.
    Markl GE; Strunz-Lehner C; Egen-Lappe V; Hasford J
    Arch Gynecol Obstet; 2007 Jun; 275(6):461-7. PubMed ID: 17136550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of treatment guidelines and implementation of a quality assurance program on quality of care in endometrial cancer.
    du Bois A; Strutas D; Buhrmann C; Traut A; Ewald-Riegler N; Kommoss S; Gomez R; Harter P
    Onkologie; 2009 Sep; 32(8-9):493-8. PubMed ID: 19745593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of moderate-to-severe psoriasis in clinical practice: a survey of Spanish dermatologists].
    Moreno-Ramírez D; Fonseca E; Herranz P; Ara M
    Actas Dermosifiliogr; 2010 Dec; 101(10):858-65. PubMed ID: 21159262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An introduction to an evidence-based approach to interventional techniques in the management of chronic spinal pain.
    Manchikanti L; Singh V; Helm S; Schultz DM; Datta S; Hirsch JA;
    Pain Physician; 2009; 12(4):E1-33. PubMed ID: 19668280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appropriate prescribing in the elderly: an investigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improved prescribing in the elderly tool to identify inappropriate use of medicines in the elderly in primary care in Ireland.
    Ryan C; O'Mahony D; Kennedy J; Weedle P; Barry P; Gallagher P; Byrne S
    J Clin Pharm Ther; 2009 Aug; 34(4):369-76. PubMed ID: 19583669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medication after hospitalization for acute coronary syndrome: Determinants of individual drug changes].
    Löffert S; Thüm S; Ommen O; van Eickels D; Ernstmann N; Höpp HW; Pfaff H
    Dtsch Med Wochenschr; 2009 Mar; 134(13):623-8. PubMed ID: 19294603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.